In November, there was a sizeable reduction in the number of short positions held by Masimo Company (NASDAQ: MASI). There were 2,240,000 shares available for a short sale as of November 30. This represents a decrease of 14.8% compared to the amount of 2,630,000 shares that were available for a short sale on November 15. Short sales account for approximately 4.6% of the total number of shares issued by the company. As a result, it is possible to derive the current short-interest ratio of 3.2 days based on an average trading volume of 704,300 shares. This ratio can be found in the table below.
Masimo, Inc. (NASDAQ: MASI) most recently disseminated a press release on Tuesday, November 8, containing their quarterly earnings. The medical equipment supplier reported earnings per share for the quarter of $1.00, an increase of $0.08 compared to the average estimate of $0.92 for the quarter. The analysts’ projections for the company’s revenue during the quarter ranged between $533.96 million and 549.30 million dollars. The return on equity for Masimo came in at 18.04 percent, while the net margin for the company was 9.78 percent. Sell-side analysts anticipate that Masimo will generate $4.45 per share earnings during the current fiscal year.
There have been multiple reports concerning the MASI stock that analysts have distributed. Masimo was mentioned for the very first time in a research report on Tuesday, September 13, when it was made available to the public by Loop Capital. They suggested investing in the company’s stock and setting a price objective of $206.00 for the share price. Masimo was the first company Jefferies Financial Group covered in a research report released on October 12 and was part of the company’s regular coverage. They provided the stock with a recommendation of “buy” and estimated that the price of the stock would rise to $180.00 shortly. StockNews.com debuted its coverage of Masimo with the publication of a research study on October 12 (Wednesday), the date of the website’s launch. They advised their clients to “hold” the stock moving forward. BTIG Research upgraded Masimo from a “neutral” rating to a “buy” rating and set a price objective of $180.00 on the company’s shares in a research note issued on Thursday. BTIG Research also set this price objective for the company’s shares. Stifel Nicolaus upgraded Masimo from a “hold” rating to a “buy” rating, and their price target was raised from $162.00 to $172.00 in a research report released on Monday, September 12. Both of these alterations were carried out. Seven market researchers have suggested that investors purchase company shares, while only two have suggested that investors keep their holdings the same. According to the information provided by Bloomberg, the average price target for Masimo is $188.25, and the general recommendation for the company is a “Moderate Buy.”
On Friday, the price of a single share of NASDAQ: MASI stock was set at $142.59, and trading began. The company’s market capitalization is $7.50 billion, the price-to-earnings ratio of the stock is 47.22, and the company has a beta of 0.88. $135.66 is the company’s moving average price over the past 50 days, and $140.35 is the company’s average price over the past 200 days. The debt-to-equity ratio, the current ratio, and the quick ratio are all equal to 0.76, whereas the current and quick ratios are equal to 1.28. The current price of Masimo is $299.78, which is higher than the one-year low of $108.89 but still lower than the one-year high.
On Friday, November 11, Masimo Inc. Chief Executive Officer Joe E. Kiani bought 7,784 shares of the company’s stock, as reported in the news regarding Masimo. The total cost of the transaction was $1,006,237.68, which works out to an average price of $129.27 per share for the acquisition of the shares. Following the successful transaction completion, the company’s CEO is now the owner of 7,784 shares of the company, which have a combined value of approximately $1,006,237.68. This page contains the filing containing the information about the transaction provided to the Securities and Exchange Commission (SEC). You can access the filing by clicking here. In related news, Chief Executive Officer Joe E. Kiani bought 7,784 shares of the company’s stock on Friday, November 11. Other news reveals that this purchase was made. The entire transaction cost came to a total of $1,006,237.68, with the shares being purchased at an average price of $129.27 each. This resulted in a total amount of money spent on the transaction. As a result of the transaction’s completion, the company’s chief executive officer now directly owns 7,784 shares of the company, which have a value of $1,006,237.68. Follow the link, which will take you to a filing submitted to the Securities and Exchange Commission. You will have the opportunity to acquire additional information regarding the transaction. Additionally, on November 14, Joe E. Kiani, the company’s CEO, bought an additional 31,994 shares of the corporation’s stock. The number of shares was acquired for a total expenditure of $3,966,936.06, which works out to an average price of $123.99 per share. After the transaction was completed without a hitch, the Chief Executive Officer had direct control over 39,778 of the company’s shares, which have a value of $4,932,074.22. You should look in this location if you are looking for the disclosure that pertains to this transaction. The current ownership of the company’s stock by company insiders is 9.70%.
Large investors have been active in the MASI stock market over the past few months, buying and selling shares on multiple occasions. The Arizona State Retirement System bought an additional 0.5 percent of Masimo stock during the second quarter, bringing the total amount of its shares to 99.5 percent. The Arizona State Retirement System now has 14,679 shares of the medical equipment provider’s stock, which are currently valued at $1,918,000 after purchasing an additional 76 shares during the most recent quarter. These shares were purchased for a total of $1,918,000. During the first three months of 2018, Lazard Asset Management LLC increased Masimo’s total ownership by 20.0%. After making an additional purchase of 81 shares during the most recent quarter, Lazard Asset Management LLC now owns 485 shares in the medical equipment provider. These shares are currently valued at $70,000 and give the company a market capitalization of Lazard Asset Management LLC. Meeder Asset Management Inc. increased the proportion of Masimo holdings it held in its portfolio by 61.3% during the second quarter. After making a new purchase of 84 shares during the most recent quarter, Meeder Asset Management Inc. now owns 221 shares of the medical equipment provider’s stock. These shares have a value of $29,000, and the company’s holdings are currently valued at $29,000. IFP Advisors Inc. increased the amount of Masimo stock owned by 123.6% during the third quarter of the fiscal year. IFP Advisors Inc. now has 161 shares of the medical equipment provider’s stock, valued at $30,000, following the purchase of 89 additional shares during the most recent quarter. During the second quarter, CWM LLC increased the amount of Masimo stock owned by 8.4%, making this the last and most important point. After purchasing an additional 91 shares during the most recent quarter, CWM LLC has a total of 1,173 shares of the stock in the company, which has a market cap of $153,000. This brings the total number of shares owned by the company to 1,173. The vast majority of the company’s stock is owned by institutional investors and hedge funds, which account for 93.31 percent of the total.